A Message from Allergan on Therapeutic Products and Patient Care and Compliance

As you know, the products of Allergan that you purchase under the oversight and direction of an InstantScripts doctor through this portal are medicines (therapeutic products) registered with the Therapeutic Goods Administration and subject to Poisons Scheduling under the National Poisons Schedule including BOTOX brand toxin (botulinum toxin) and Juvederm (hyaluronic acid) which are both Schedule 4 products.

You must ensuring compliance with applicable controls to ensure proper patient care both in relation to prescribing and administering scheduled medicines but also in relation to product delivery, storage, handling and record keeping.

The medical practitioner oversight available to you in relation to Allergan product purchased through InstantCosmetics is also confirmed by the medical practitioner declaration in your account form with Allergan. You must notify us immediately in writing of any change to the nominated medical practitioner associated with your account.

We require you to obtain and comply with medical practitioner oversight in relation to patient prescribing, product administration, product handling, product storage, premises and record keeping. You must inform yourself in relation to applicable product handling, storage and record keeping and risk management requirements for your clinic, given the circumstances of your business and your dealings with Allergan’s products, including having appropriate equipment. You must have a system for ensuring your staff dealing with Allergan products are trained in these requirements and keep that training up to date, including training for patient medical emergencies and adverse event reporting.

Importantly, you must keep your nominated medical practitioner advised in relation to any patient safety issues that arise, and make records available to them as reasonably requested at any time in connection with patient safety. Also, we require you to make records available to us as we may reasonably require at any time in connection with patient safety issues.